Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome
- 1 January 2001
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 5 (2) , 78-85
- https://doi.org/10.1016/s1201-9712(01)90030-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- What Makes Cryptococcus neoformans a Pathogen?Emerging Infectious Diseases, 1998
- Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen‐presenting cells inhibits the T‐suppressor response and enhances delayed‐type hypersensitivity and survivalImmunology, 1997
- Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?Zentralblatt für Bakteriologie, 1996
- Phagocytosis and growth inhibition of Cryptococcus neoformans by human alveolar macrophagesAIDS, 1996
- Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils.Journal of Clinical Investigation, 1996
- Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.Journal of Clinical Investigation, 1993
- Manifestations of Pulmonary Cryptococcusis in Patients with Acquired Immunodeficiency SyndromeClinical Infectious Diseases, 1990
- Infections withCryptococcus neoformansin the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Primary Complex of Cryptococcus and Pulmonary Lymph NodesThe Journal of Infectious Diseases, 1974
- Cryptococcosis: Current statusThe American Journal of Medicine, 1968